Dr Nicole Williams, Associate Professor, is the OSU #ISPY2 site-PI, is the director of the OSU #BreastCancer CARE clinic (#geriOnc) and was recently named Fellowship Director for the OSU #BreastCancer #MedOncFellowship Accepting applicants now 🙂 @OSUCCC_James @OSUWexMed

#Epiverse

It's #DAG time

Any thoughts on the DAG below representing the relationship between receipt of #surgery and #death within 1 year of diagnosis in patients with #ColonCancer?

Clear enough? Did I forget something?

#GeriOnc

Look ma, it's me! Huge kudos to Drs. @HiraSMian@twitter.com, @tanyawildes@twitter.com and Mark Fiala for spearheading this extremely important SEER-Medicare study assessing how frailty dynamically changes throughout lines of therapy in myeloma. #mmsm #ASH22 #gerionc

This is one of the best things I've seen at @ASH_hematology@twitter.com. #ASH22 #gerionc cc @MayaAbdallah_MD@twitter.com @Jacawalk@twitter.com @MirNabiel@twitter.com @tanyawildes@twitter.com

RT @tanyawildes@twitter.com

13 seconds, give or take. That’s all it takes to assess physical performance in an older adult with myeloma, as demonstrated by @TMSchmidtMD@twitter.com for Ciara Freeman at #ASH22

It's going to be a great year for @ASH_hematology@twitter.com #ASH22 myeloma! Huge congratulations to Dr. @HiraSMian@twitter.com on spearheading assessments of dynamic frailty in #mmsm and Dr. @bdermanmd@twitter.com on a MRD-adapted maintenance discontinuation trial. #gerionc

Hello #GeriOnc community & others, with colleagues we described age-related diff in #coloncancer and #rectalcancer #survival using #SEER data in the #US.
Our work is available on medrxiv server and ready for your comments:
https://medrxiv.org/cgi/content/short/2022.11.29.22282871v1

#cancer #epiverse #epidemiology #description #AgeDisparities #GeriatricOncology